revealed that the levels of fasting glucose are increased in 9 individuals with loss-of-function (LOF) variation in TXNDC5, indicating TXNDC5 can be identified as a potential determinant of type 1 diabetes risk (98). The gene discussed is TXNDC5; the disease is type 1 diabetes mellitus.